Korea Health Ministry Rebuts Reports Of Its Retreat From Price Remapping
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's Ministry of Health, Welfare and Family Affairs rebutted a news report that the ministry will delay announcement of the "list of re-registered drugs," which specifically names drugs that will be covered by the national insurance policy
You may also be interested in...
Korea FDA Posts Names Of Companies Approved For Bioequivalence Tests
SEOUL - Stepping back from its earlier harsh stance on local generic pharmaceutical makers, Korea FDA said it is now posting each week the names of local generic makers that successfully obtain approvals for bioequivalence tests, which compare the bio-availability of generics to original products
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).